Target intelligence / Profile preview

Joint cartilage and periarticular tissues

Molecular classification
Other
01

Overview

Joint cartilage and periarticular tissues represent the collective anatomical structures that form and support functional joints, including hyaline cartilage, the synovial membrane, joint capsule, ligaments, and tendons. The primary biological role of these tissues is to facilitate smooth, low-friction movement and provide shock absorption to protect the underlying bone during physical activity (StatPearls, 2023). In various arthritic conditions, these tissues become the site of chronic inflammation and structural breakdown, driven by the overproduction of degradative enzymes and pro-inflammatory cytokines (NIH, 2022). While pharmacological interventions like NSAIDs, corticosteroids, and biologics are administered to treat joint-related diseases, they target specific molecular entities within these tissues rather than the tissue complex as a whole. Therefore, this term describes a physiological environment and disease site rather than a single, discrete therapeutic target (PubMed, 2021). Therapeutic strategies often focus on preserving the integrity of the extracellular matrix or reducing synovial inflammation to maintain joint mobility. Understanding the interplay between these tissues is crucial for developing regenerative therapies and managing chronic pain associated with musculoskeletal disorders.

Other names
Articular cartilageSynovial joint tissuesPeriarticular structuresJoint complex
02

Mechanism of action

Drugs acting within these tissues typically function by inhibiting inflammatory mediators (e.g., COX enzymes, TNF-alpha), providing mechanical lubrication (viscosupplementation), or modulating immune responses to prevent tissue degradation.

03

Biological functions

Structural supportShock absorptionJoint lubricationFacilitation of movement
04

Disease associations

OsteoarthritisRheumatoid arthritisGoutBursitisTendonitisAnkylosing spondylitis
05

Safety considerations

Gastrointestinal toxicity (NSAIDs)Increased risk of infection (Biologics)Cartilage atrophy with chronic corticosteroid useInjection site reactions
06

Interacting drugs

Hyaluronic acid

7 more in the full profile.

07

Biomarkers

C-terminal telopeptide of type II collagen (CTX-II)Cartilage oligomeric matrix protein (COMP)Matrix metalloproteinases (MMPs)Synovial fluid leukocyte count

Beyond the preview

Go deeper on Joint cartilage and periarticular tissues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joint cartilage and periarticular tissues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call